Download the FAQs for Source and Recovered COVID-19 Plasma Donors in: English; French; German; Italian; Spanish

WHAT IS PLASMA?

Plasma is the straw-colored liquid portion of blood comprised of water, salts, and proteins which contains numerous proteins essential for proper functioning of the body. insufficient levels of any one plasma protein prevents the body from carrying out vital functions, causing a variety of chronic and life-threatening medical conditions.

WHAT IS SOURCE PLASMA?

Source plasma is plasma that is collected from healthy, compensated donors and is used exclusively to make plasma protein therapies.

WHAT IS COVID-19 PLASMA?

COVID-19 plasma is plasma collected from patients who have recovered from COVID-19. In addition to the proteins found in plasma, COVID-19 plasma contains pathogen-specific antibodies.

WHO CAN DONATE SOURCE PLASMA?

Source plasma donors undergo a rigorous donation screening process, which determines donor eligibility, and must maintain a healthy lifestyle to remain a qualified donor.

WHO CAN DONATE COVID-19 PLASMA?

In addition to meeting Source plasma donor eligibility criteria, individuals must have had a prior diagnosis of COVID-19 by a laboratory test and must have complete resolution of symptoms for at least 14 days prior to donation.

THERAPIES MADE FROM SOURCE PLASMA TREAT:

• Alpha-1 Antitrypsin Deficiency
• Bleeding disorders, such as Hemophilia
• Chronic Inflammatory Demyelinating Polyneuropathy
• Hereditary Angioedema
• Primary and Secondary Immune Deficiencies
• Acute conditions, such as shock, trauma, and burns

THERAPIES MADE FROM COVID-19 PLASMA, AFTER TESTING THROUGH CLINICAL TRIALS, COULD POTENTIALLY TREAT:

• Patients with COVID-19
• Pre- and post-exposure prophylaxes for those at high risk for contracting COVID-19, such as:
  
  • Health care workers
  • Public health service staff
  • Individuals with antibody deficiencies, chronic lung disease, or other chronic conditions

 

EVERY DONATION COUNTS!
SOURCE PLASMA DONATIONS NEEDED TO TREAT 1 PATIENT FOR 1 YEAR*
130:	900:	1200:
Primary immunodeficiency disease	Alpha-1 antitrypsin deficiency	Hemophilia A
*Based on 150 lb. adult